Anti-neutrophil cytoplasmic autoantibodies (ANCA) specifically associated with Wegener's granulomatosis were found to
Introduction
Immune mechanisms are generally assumed to play a pathogenetic role in Wegener's granulomatosis (WG; reviewed in ref- erence 1) .' The most prominent presenting symptoms of the disease are localized at sites of contact between the body and the outer world (2) (3) (4) . Exacerbations appear to be associated with infections (5) and it was recently reported that successful treatment and prevention of exacerbations of WG were achieved with antimicrobial agents (6, 7) . The granulomatous inflammation as well as the vasculitis and glomerulonephritis of WG show a favorable response to treatment with antiinflammatory and immunosuppressive drugs (1, 2) . Therefore, derailment of an inflammatory response to certain stimuli seems to be an important factor in the pathogenesis of WG.
In serum of patients with active WG, autoantibodies against intracellular components of neutrophils and monocytes have been detected (8) (9) (10) (11) (12) (13) (14) . Two distinct staining patterns of these anti-neutrophil cytoplasmic autoantibodies (ANCA) have been observed (Fig. 1) . The originally described ANCA produce cytoplasmic staining of ethanol-fixed cytospins of neutrophils (C-ANCA). The perinuclear staining antibodies against MPO, which Falk and Jennette (15) and we (16) independently identified more recently, are called P-ANCA. Indistinguishable P-ANCA staining is observed also with autoantibodies against elastase (16), and against as yet unidentified antigens ( 17) .
Unlike anti-MPO and antielastase (both P-ANCA), C-ANCA is a specific and sensitive marker for active WG and microscopic polyarteritis (10-14), although exceptions have been noted (18) (19) (20) . The serum titer of C-ANCA correlates with disease activity (10- 14) , and exacerbations of WG were invariably found to be preceded by a significant increase ofthe C-ANCA titer (14) . This suggests a possible role ofC-ANCA in the pathogenesis of WG and warrants identification of the target antigen(s) of these antibodies.
We here report the partial characterization of C-ANCA antigen as a diisopropylfluorophosphate (DFP)-binding protein (serine protease) of M, 29 ,000 in the primary granules (lysosomes) of human neutrophils, which is distinct from neutrophil elastase (NE) and cathepsin G. film was from Eastman Kodak Co. (Rochester, NY). Neuraminidase was obtained from Behring AG (Marburg, FRG) . N-Glycanase was from Genzyme (Boston, MA).
Human sera. For this study we used a pool of sera from 5 healthy donors (normal control), and sera obtained from 91 individual patients. All patients' sera had been submitted to our laboratory for routine ANCA testing. Sera from 41 patients with a diagnosis of WG, established in the referring hospitals on the basis of histopathological findings and/or classical clinical symptoms (21) , were selected. These sera contained significant titers of ANCA, producing the characteristic C-ANCA in the standard ANCA immunofluorescence test (IFT); i.e., indirect immunofluorescence on ethanol-fixed, air-dried cytospins of normal donor leukocytes (10). 47 consecutive sera giving negative results in the standard ANCA IFT and 3 selected sera producing P-ANCA were used as controls.
Serum P-ANCA-I came from an 80-yr-old woman who presented with malaise, fever, arthralgia, and a skin rash. Skin biopsy showed necrotizing vasculitis of small arteries. Serum P-ANCA-2 came from a 73-yr-old man with general malaise, renal failure, and infiltrative abnormalities on a chest x ray. Muscle biopsy showed an unclassifiable vasculitis. Serum P-ANCA-3 came from a 48-yr-old man with rapidly progressive idiopathic crescentic glomerulonephritis.
Proteins and antisera. Purified human NE (EC 3.4.21.37) prepared from purulent sputum (22) and rabbit anti-NE were kindly provided by Dr Subcellular fractionation of neutrophils. Subcellular fractionation of neutrophils by Percoll density-gradient centrifugation and marker protein analysis in the fractions thus obtained were performed in essence as described by Borregaard et al. (29) . On the basis of distribution of marker proteins gradient fractions were combined to form four pools: pool a contained only azurophilic granules, pool # contained the specific granules plus some azurophilic granules, pool -y contained the plasma membranes and phosphasomes, and pool a contained the cytosol. Percoll was removed by ultracentrifugation (60 min, 220,000 g).
From pools a, fl, and 'y the insoluble membrane proteins were separated from soluble proteins as follows. After six freeze-thaw cycles the pools were extracted for 45 min on ice in a 50 mM glycine, 10 mM Na2HPO4/NaH2PO4 buffer of pH 6.8, containing 3.5 M ureum and 1 M KC1. Thereafter, soluble and insoluble materials were separated by centrifugation at 220,000 g for 90 min and dialyzed against PBS (29) .
Western blotting. For Western blot analysis whole cell extracts, subcellular fractions, and supernatants of stimulated neutrophils were electrophoresed under nonreducing conditions on 1.5-mm SDS polyacrylamide gels (10 or 12.5%) at concentrations equivalent to 2 X 107 cells/cm gel. NP-40 extracts (1%) of whole neutrophils (2 x 108 cells/ ml) were prepared for gel electrophoresis by addition of an equal volume ofconcentrated sample buffer (7% SDS, 0.18 M Tris/HCl, pH 6.8, Figure 2 . Western blot-analysis of 1% NP-40 lysate of normal donor neutrophils. Extracts from purified neutrophils were prepared at concentrations equivalent to 2 X 108 cells/ml by incubation for 1 h at 4VC in 1% (vol/vol) NP-40 in 20 mM Tris, pH 6.8. The extracts were cleared by centrifugation (10 min, 12,000 g) in the cold. For Western blot analysis samples from these extracts were electrophoresed at a concentration equivalent to 2 X 107 cells/ cm gel. Lanes A and N, normal control sera; lanes B-G, C-ANCA-positive sera; lane H, serum containing multiple HLA antibodies; lanes I-K, sera containing antibodies against three different alloantigens (NB 1, NA 1, and NDl) expressed on neutrophil plasma membranes; lane L, serum containing antinuclear antibodies; lane M, serum containing antimitochondrial antibodies; and lane 0, ANCAnegative serum from a patient with unclassified vasculitis.
9% glycerol, and 0.5 mg/ml bromophenol blue) to achieve a sevenfold excess of SDS over NP-40. Properly diluted subcellular fractions and concentrated supernatants from stimulated neutrophils were mixed directly with sample buffer. All samples were boiled for 2 min before electrophoresis. Transfer to nitrocellulose and detection of antibody binding with '25I-labeled mouse MAb against human IgG (MH 16-1; CLB, Amsterdam, The Netherlands) were performed as described (30).
Immunoprecipitation. After dialysis against PBS the extracts and membrane preparations from subcellular neutrophil fractions (pools a, fl, and y) were supplemented with NaCI, SDS, and Triton X-100 to final concentrations of 0.5 M, 0.5% (wt/vol), and 1% (wt/vol), respectively. The samples thus obtained were radiolabeled with 1251I by the iodogen method (31) and assayed by immunoprecipitation with the protein A method described by Huisman et al. (32) . Immunoprecipitation with sheep anti-cathepsin G was performed with antibodies linked covalently to CNBr-activated Sepharose 4B. The radiolabeled preparations were diluted in immunoprecipitation buffer (4% [wt/vol] BSA, 1% [wt/vol] Triton X-100, 0.5% [wt/vol] SDS, and 0.5 M NaCl in PBS). 250-Ml aliquots were incubated overnight with either anti-cathepsin G-Sepharose or serum (5 al/precipitation) at 4°C, and subsequently with protein A-Sepharose CL-4B (5 mg/precipitation) for another 3 h. For use in sequential immunoprecipitation experiments, IgG preparations from antisera or ascitic fluid were coupled covalently to CNBr-activated Sepharose 4B. In these experiments the incubation time for each step was reduced to 60 min. The Sepharose beads were thoroughly washed in immunoprecipitation buffer, PBS, and 10 mM Tris-HCl, pH 6.8, and subsequently centrifuged through 10 and 20% sucrose solutions in 10 mM Tris-HCl, pH 6.8. Finally, the beads were 8 poly-or monoclonal antibodies against elastase, cathepsin G, and The subcellular distribution of C-ANCA antigen was studied by Percoll density-gradient centrifugation of nitrogen-cavitated neutrophils. Western blot analysis of these subcellular fractions (Fig. 3 a) revealed that in the a-fraction (which contained only azurophilic granules) a protein with M, 29 ,000 was specifically recognized by C-ANCA-positive sera. A similar protein was found in the :-fraction, although at a lower concentration. This was probably due to contamination of the fl-fraction, containing the specific granules, with some azurophilic granules. In the y-(membrane-phosphasome) and 6-(cytosol) fractions no ANCA-reactive proteins were found (Fig. 3 b) . Thus, the C-ANCA antigen apparently copurified with azurophilic granules.
Subsequently, insoluble membrane proteins were separated from soluble proteins by extraction of the a-, 13- and Iy-fractions in a buffer containing 3.5 M urea and 1 M KCl or in PBS. In radioimmunoprecipitation experiments (Fig. 4) and Western blots (not shown) the C-ANCA antigen was almost exclusively recovered from the extracts (obtained with either buffer) of the a-fraction, and trace amounts were again found in the extract ofthe 13-fraction but not in that of the y-fraction.
The membrane preparations of the different fractions did not contain detectable amounts of the antigen. In the experiment shown in Fig. 4 it can be seen that immunoprecipitated C-ANCA antigen in fact migrates as a triplet of bands with Mr 29,000, 30,500, and 32,000 (see below). Thus, the C-ANCA antigen was found to be a saline-soluble protein present in azurophilic granules of normal neutrophils.
Immunoprecipitation results with different patients' sera and correlation with staining patterns in the ANCA-IFT. (Fig. 8) . C-ANCA serum was found to precipitate three [3HJDFP-labeled bands that exactly matched the three bands immunoprecipitated from a sample ofthe same [3H]DFP-labeled preparation that had additionally been labeled with '251. The three bands precipitated from both preparations by antielastase clearly displayed a higher electrophoretic mobility than the C-ANCA-antigen triplet.
Discrimination between the C-ANCA antigen, NE, and cathepsin G. The relation between NE, cathepsin G, and the C-ANCA antigen was investigated in four independent experiments (Fig. 9 ).
Sequential immunoprecipitation with polyclonal rabbit antielastase, followed by sheep anti-cathepsin G, and finally by a C-ANCA-positive WG patient's serum or MAb 12.8 (Fig.  9 a) showed that the C-ANCA antigen is immunologically different from elastase and cathepsin G. This was confirmed when the order of incubations was reversed. Moreover, the three antigens had clearly different electrophoretic mobilities under both reducing and nonreducing conditions. Selective deglycosylation of immunoprecipitated elastase, cathepsin G, and C-ANCA antigen showed that all three proteins contain N-linked glycans (Fig. 9 b) . Moreover, the deglycosylated samples showed different electrophoretic mobility, which indicates that the C-ANCA antigen is not a glycosylation variant of either elastase or cathepsin G.
The reactivity of patients' sera, MAbs, rabbit antielastase serum, and sheep anti-cathepsin G with crude saline extract from purified azurophilic granules and with biochemically purified elastase and cathepsin G, was tested in solid-phase ELISAs (Fig. 9 c) . C-ANCA-positive patients' sera did not bind to biochemically purified elastase or cathepsin G. Also in antigen-capture ELISAs (Fig. 9 d) C-ANCA antigen proved to be distinct from elastase and cathepsin G.
Reactivity of routinely submitted patients' sera with antigens caught by different MAbs. Selected sera from 91 individual patients (submitted to our laboratory for routine ANCA testing) were tested in sandwich ELISAs with MAbs 12.8 (anti-C-ANCA antigen), NP57 (antielastase), and 4.15 (anti-MPO), and with the negative control MAb AME-l (anti-glycophorin A) as the antigen-catching antibodies. All C-ANCApositive sera (n = 41) showed specific binding only to the antigen caught by MAb 12.8 (Fig. 10) Release ofthe C-ANCA antigen upon stimulation ofprimed neutrophils. As an intracellular protein the C-ANCA antigen in resting neutrophils is not accessible to autoantibodies. However, upon inflammatory stimulation of neutrophils granule constituents can be released or appear on the cell surface. Therefore, we investigated whether stimulation of neutrophils in vitro would lead to membrane expression or exocytosis of the C-ANCA antigen into the incubation medium. Stimulation of neutrophils with the chemotactic peptide FMLP did not result in release of contents of azurophilic granules (as judged by absence of ,B-glucuronidase activity in the supernatant of these cells). In contrast, when cytochalasin B-treated neutrophils were stimulated for 20 min with FMLP, 20% of f-glucuronidase activity was recovered in the incubation medium. Western blots of the cell supernatants showed that the C-ANCA antigen had been released from cytochalasin B-treated, FMLP-stimulated neutrophils, but not from untreated, FMLP-stimulated neutrophils (Fig. 11) . Membrane expression could not be detected on either resting or stimulated neutrophils (not shown).
Discussion
In Western blots of solubilized normal donor neutrophils the antigen recognized by C-ANCA was identified as a protein of Mr 29,000. Upon subcellular fractionation by Percoll density centrifugation of nitrogen-cavitated neutrophils this C-ANCA antigen was found to copurify with the azurophilic granules, but not with the cytosol fraction or with fractions containing plasma membranes and alkaline phosphatase activity (cf. references 34-37). In the fractions containing the specific granules only trace amounts of C-ANCA antigen were found, caused by contamination of these fractions with small numbers of azurophilic granules, as was indicated by the distribution of f3-glucuronidase activity. Therefore, it is unlikely that ANCA antigen is associated with alkaline phosphatase (34) , or that it is located in the specific granules (35) . Localization of the C-ANCA antigen in the azurophilic granules is in agreement with its earliest appearance in the promyelocytic differentiation stage of immature myeloid cells (38) . Extraction ofpurified azurophilic granules with physiological saline solutions showed that the C-ANCA antigen is saline soluble and contained in these granules rather than being associated with the granule membranes. In vitro stimulation of viable, cytochalasin B-treated neutrophils with the chemotactic peptide FMLP indeed caused release of C-ANCA antigen from the cells into the incubation medium, together with the azurophilic granule-enzyme f3-glucuronidase.
Immunochemical analysis of the extracts revealed that the C-ANCA antigen is in fact a protein triplet consisting of a major band of M, 29 C-ANCA antigen is a serine protease. However, the C-ANCA antigen could be readily discriminated from elastase and cathepsin G by their different electrophoretic mobility in SDS-PAGE under reducing and nonreducing conditions. N-Glycanase treatment showed that C-ANCA antigen is not a glycosylation variant of elastase or cathepsin G. Moreover, C-ANCA-positive patients' sera did not bind to purified NE or cathepsin G in a solid-phase ELISA. In addition to elastase and cathepsin G, a third (neutral) protease of neutrophil azurophilic granules has been described as "slowly moving esterolytic activity" or "proteinase 3," and was recently demonstrated to cause emphysema after intratracheal instillation in hamsters (39-41). Proteinase 3 was not available to us during our studies, but in preliminary experiments after the purification protocol described by Kao et al. (41) we obtained evidence that C-ANCA antigen may indeed be identical to proteinase 3 + --decanoyl phorbol acetate (1 ,ug/ml) stimulated PMN by immunoaffinity chromatography using purified IgG from a C-ANCA-positive patient's serum and shown that the characteristics of this antigen are strikingly similar to those reported in the literature for proteinase 3.
The results of our study show that the C-ANCA-staining pattern represents a uniform specificity for this 29,000 serine protease. In contrast, the P-ANCA pattern as produced by anti-MPO antibodies (15, 16 ) was also obtained with autoantibodies against elastase (16) or granulocyte-specific antinuclear antibodies (17) . Moreover, in some P-ANCA sera combinations of these antibodies, also with anti-29;000 antibodies (C-ANCA), have been detected.
The originally described WG-specific C-ANCA thus represent only one specificity from a class of autoantibodies against myeloid-specific lysosomal enzymes. Anti-MPO has been reported in association with idiopathic and vasculitis-associated crescentic glomerulonephritis, but also with extrarenal disease. Antielastase was also found in association with vasculitic disorders (15, 16, 18, 19) . However, the disease specificity ofthese autoantibodies has not yet been studied extensively.
In resting neutrophils the ANCA antigens are present only intracellularly and not on the plasma membrane, and therefore are not accessible to circulating autoantibodies. However, upon stimulation neutrophils release lysosomal enzymes and immune complexation with ANCA may occur. Immune complex formation might, in itself, sustain or even amplify an inflammatory process. Alternatively, binding of ANCA might modulate the putative enzymatic function of released ANCA antigen and/or interfere with their inactivation.
In conclusion, cytoplasmic staining neutrophil autoantibodies present in the blood of patients with WG are directed against a soluble and releasable serine protease of azurophilic granules. This serine protease is distinct from elastase and cathepsin G and may be identical to proteinase 3. In the blood of patients with vasculitic disorders autoantibodies against other myeloid lysosomal enzymes may also be present, such as anti-MPO or antielastase. Further investigations are necessary to study the putative pathogenetic role of such autoantibodies in these diseases.
